Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
Multiple myeloma - ScienceDirect
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
The biology of immunoglobulin free light chains and kidney injury - Kidney International
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
247 SPEP It Up
Novel Prognostic Modalities in Multiple Myeloma | IntechOpen
Light Chain Multiple Myeloma: Your Ultimate Guide | MyMyelomaTeam
New insights into the pathogenesis and treatment of heavy chain deposition disease - Kidney International
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Clinicopathological and prognostic study of primary IgA nephropathy with light chain λ restriction in the mesangial deposits - ScienceDirect
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment | American Society of Nephrology
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
AL - Amyloidosis Foundation
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Kappa and Lambda Light Chains - The Myeloma Crowd
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table1-1.png "PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar")
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
